Animal Intestinal Health Market Report 2026

Animal Intestinal Health Market Report 2026
Global Outlook – By Product (Phytogenics, Probiotics, Immunostimulants, Prebiotics), By Source (Microbial, Plant-Based), By Form (Dry, Liquid), By Livestock (Poultry, Swine, Ruminant, Aquaculture) – Market Size, Trends, Strategies, and Forecast to 2035
Animal Intestinal Health Market Overview
• Animal Intestinal Health market size has reached to $4.5 billion in 2025 • Expected to grow to $7.67 billion in 2030 at a compound annual growth rate (CAGR) of 11.2% • Growth Driver: Nurturing Livestock And Sustainability And The Role Of Animal Intestinal Health In Driving Growth In Agriculture • Market Trend: Technology Revolutionizes Animal Intestinal Health Market • Asia-Pacific was the largest region in 2025.What Is Covered Under Animal Intestinal Health Market?
Animal intestinal health is described as a steady state where the microbiome and the intestinal tract are in symbiotic equilibrium and where intestinal dysfunction does not limit the animal's welfare or performance. The main types of products in animal intestinal health include phytogenics, probiotics, immunostimulants, and prebiotics. Phytogenics refers to plant-derived products that are added to feed to enhance feed palatability or animal performance. The various sources are microbial and plant-based. The various forms include dry and liquid that is used in various livestock such as poultry, swine, ruminant, and aquaculture.
What Is The Animal Intestinal Health Market Size and Share 2026?
The animal intestinal health market size has grown rapidly in recent years. It will grow from $4.5 billion in 2025 to $5.01 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing prevalence of intestinal disorders in livestock, growth of intensive farming practices, rising awareness of animal gut health, demand for natural feed additives, adoption of probiotics and phytogenics.What Is The Animal Intestinal Health Market Growth Forecast?
The animal intestinal health market size is expected to see rapid growth in the next few years. It will grow to $7.67 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to advancements in microbial probiotics, growing use of plant-based feed additives, increasing focus on aquaculture and ruminant gut health, development of innovative prebiotics and immunostimulants, expansion of liquid feed supplement solutions. Major trends in the forecast period include rising adoption of probiotics and prebiotics in livestock feed, growing use of phytogenics and herbal ingredients for gut health, increasing focus on aquaculture and poultry intestinal health, development of natural and synthetic immunostimulants, expansion of liquid and dry feed supplement forms.Global Animal Intestinal Health Market Segmentation
1) By Product: Phytogenics, Probiotics, Immunostimulants, Prebiotics 2) By Source: Microbial, Plant-Based 3) By Form: Dry, Liquid 4) By Livestock: Poultry, Swine, Ruminant, Aquaculture Subsegments: 1) By Phytogenics: Essential Oils, Plant Extracts, Herbal Ingredients 2) By Probiotics: Bacterial Probiotics, Yeast Probiotics 3) By Immunostimulants: Natural Immunostimulants, Synthetic Immunostimulants 4) By Prebiotics: Fructooligosaccharides (FOS), Galactooligosaccharides (GOS), Mannanoligosaccharides (MOS)What Is The Driver Of The Animal Intestinal Health Market?
The growing adoption of livestock farming is expected to propel the growth of the animal intestinal health market going forward. Livestock farming is the agricultural practice of breeding, raising, and managing domesticated animals for various purposes, primarily to produce food, fiber, and other by-products. A focus on intestinal health in livestock farming contributes to better overall animal performance, enhanced feed efficiency, productivity, and nutrient absorption, reduces the need for antibiotics, and contributes to long-term sustainability. For instance, in July 2024, according to the National Agricultural Statistics Service, a US-based Department of Agriculture, expenditures by livestock farms increased by 4.7% between 2022 and 2023. In 2023, livestock farm expenditures reached $229.4 billion. Therefore, the growing adoption of livestock farming is expected to propel the growth of the animal intestinal health industry.Key Players In The Global Animal Intestinal Health Market
Major companies operating in the animal intestinal health market are Koninklijke DSM N.V., Archer-Daniels-Midland Company, Kemin Industries Inc., E. I. du Pont de Nemours and Company, Cargill Incorporated, Novozymes A/S, Nutreco N.V., Chr. Hansen Holding A/S, Bluestar Adisseo Company, Dr. Eckel Animal Nutrition GmbH & Co. KG, Alltech Inc., Evonik Industries AG, Lallemand Animal Nutrition, Biorigin, AB Vista, Land O'Lakes Inc., Lesaffre, Unique Biotech, Pure Cultures LLC, Agrihealth, Arm & Hammer Animal and Food Production, BENEO GmbH, Delacon Biotechnik Ges.m.b.H., Pancosma SA, Phytobiotics Futterzusatzstoffe GmbH, Vetpharma Animal Health S.L., Vetoquinol S.A., Virbac Corporation, Wacker Chemie AG, Zoetis Inc.Global Animal Intestinal Health Market Trends and Insights
Major companies operating in the market are developing advanced and innovative products to strengthen their position in the market. Advanced and innovative products refer to new or improved solutions that offer enhanced performance, precision, or capabilities compared to existing offerings in the market. For instance, in June 2024, the Alltech U.S. Pork Team unveiled Levelset at the World Pork Expo, a new product designed to enhance gut health in pigs. Levelset leverages advanced nutritional science to support optimal digestive function, ensuring better nutrient absorption and overall health in swine. This innovative product aims to improve the well-being of pigs and, ultimately, the efficiency of pork production.What Are Latest Mergers And Acquisitions In The Animal Intestinal Health Market?
In July 2023, dsm-firmenich AG, a Switzerland/Netherlands-based provider of nutrition, health, and bioscience solutions, including ingredients and technologies for animal nutrition and gut health, acquired Adare Pharma Solutions’s Adare Biome for an undisclosed amount. With this acquisition, dsm-firmenich expanded its capabilities in the animal intestinal health and microbiome management market by integrating Adare Biome’s postbiotic research, development, and manufacturing expertise to strengthen its gut health solutions portfolio for pets and production animals. Adare Pharma Solutions’s Adare Biome is a France/USA-based developer and producer of postbiotics and digestive health ingredients used in applications for human, pet, and production animal gut health.Regional Outlook
Asia-Pacific was the largest region in the animal intestinal health market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Animal Intestinal Health Market?
The animal intestinal health market consists of sales of eubiotics and synbiotic products for animal gut health. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Animal Intestinal Health Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $5.01 billion |
| Revenue Forecast In 2035 | $7.67 billion |
| Growth Rate | CAGR of 11.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Source, Form, Livestock |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Koninklijke DSM N.V., Archer-Daniels-Midland Company, Kemin Industries Inc., E. I. du Pont de Nemours and Company, Cargill Incorporated, Novozymes A/S, Nutreco N.V., Chr. Hansen Holding A/S, Bluestar Adisseo Company, Dr. Eckel Animal Nutrition GmbH & Co. KG, Alltech Inc., Evonik Industries AG, Lallemand Animal Nutrition, Biorigin, AB Vista, Land O'Lakes Inc., Lesaffre, Unique Biotech, Pure Cultures LLC, Agrihealth, Arm & Hammer Animal and Food Production, BENEO GmbH, Delacon Biotechnik Ges.m.b.H., Pancosma SA, Phytobiotics Futterzusatzstoffe GmbH, Vetpharma Animal Health S.L., Vetoquinol S.A., Virbac Corporation, Wacker Chemie AG, Zoetis Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Animal Intestinal Health market was valued at $4.5 billion in 2025, increased to $4.5 billion in 2026, and is projected to reach $7.67 billion by 2030.
request a sample hereThe expected CAGR for the Animal Intestinal Health market during the forecast period 2025–2030 is 11.2%.
request a sample hereMajor growth driver of the market includes: The growing adoption of livestock farming is expected to propel the growth of the animal intestinal health market going forward. Livestock farming is the agricultural practice of breeding, raising, and managing domesticated animals for various purposes, primarily to produce food, fiber, and other by-products. A focus on intestinal health in livestock farming contributes to better overall animal performance, enhanced feed efficiency, productivity, and nutrient absorption, reduces the need for antibiotics, and contributes to long-term sustainability. For instance, in July 2024, according to the National Agricultural Statistics Service, a US-based Department of Agriculture, expenditures by livestock farms increased by 4.7% between 2022 and 2023. In 2023, livestock farm expenditures reached $229.4 billion. Therefore, the growing adoption of livestock farming is expected to propel the growth of the animal intestinal health market. in the Animal Intestinal Health market. For further insights on this market,
request a sample hereThe animal intestinal health market covered in this report is segmented –
1) By Product: Phytogenics, Probiotics, Immunostimulants, Prebiotics
2) By Source: Microbial, Plant-Based
3) By Form: Dry, Liquid
4) By Livestock: Poultry, Swine, Ruminant, Aquaculture Subsegments:
1) By Phytogenics: Essential Oils, Plant Extracts, Herbal Ingredients
2) By Probiotics: Bacterial Probiotics, Yeast Probiotics
3) By Immunostimulants: Natural Immunostimulants, Synthetic Immunostimulants
4) By Prebiotics: Fructooligosaccharides (FOS), Galactooligosaccharides (GOS), Mannanoligosaccharides (MOS)
request a sample here1) By Product: Phytogenics, Probiotics, Immunostimulants, Prebiotics
2) By Source: Microbial, Plant-Based
3) By Form: Dry, Liquid
4) By Livestock: Poultry, Swine, Ruminant, Aquaculture Subsegments:
1) By Phytogenics: Essential Oils, Plant Extracts, Herbal Ingredients
2) By Probiotics: Bacterial Probiotics, Yeast Probiotics
3) By Immunostimulants: Natural Immunostimulants, Synthetic Immunostimulants
4) By Prebiotics: Fructooligosaccharides (FOS), Galactooligosaccharides (GOS), Mannanoligosaccharides (MOS)
Major trend in this market includes: Technology Revolutionizes Animal Intestinal Health Market For further insights on this market,
request a sample hereMajor companies operating in the Animal Intestinal Health market are Major companies operating in the animal intestinal health market are Koninklijke DSM N.V., Archer-Daniels-Midland Company, Kemin Industries Inc., E. I. du Pont de Nemours and Company, Cargill Incorporated, Novozymes A/S, Nutreco N.V., Chr. Hansen Holding A/S, Bluestar Adisseo Company, Dr. Eckel Animal Nutrition GmbH & Co. KG, Alltech Inc., Evonik Industries AG, Lallemand Animal Nutrition, Biorigin, AB Vista, Land O'Lakes Inc., Lesaffre, Unique Biotech, Pure Cultures LLC, Agrihealth, Arm & Hammer Animal and Food Production, BENEO GmbH, Delacon Biotechnik Ges.m.b.H., Pancosma SA, Phytobiotics Futterzusatzstoffe GmbH, Vetpharma Animal Health S.L., Vetoquinol S.A., Virbac Corporation, Wacker Chemie AG, Zoetis Inc.
request a sample hereAsia-Pacific was the largest region in the animal intestinal health market share in 2025. The regions covered in the animal intestinal health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here